Older people like President Trump are at more risk from COVID-19 because of how the immune system ages

Older coronavirus patients face grimmer outlooks. A virologist explains the aging-related changes in how immune systems work that are to blame.

Brian Geiss, Associate Professor of Microbiology, Immunology & Pathology, Colorado State University • conversation
Oct. 2, 2020 • ~7 min

One small part of a human antibody has the potential to work as a drug for both prevention and therapy of COVID-19

Antibodies are great for neutralizing viruses. But they are big and bulky. Antibody engineers are now creating smaller synthetic antibody-like molecules that may be better for fighting COVID-19.

Dimiter Stanchev Dimitrov, Professor of Medicine and Director, Center for Antibody Therapeutics, University of Pittsburgh • conversation
Oct. 1, 2020 • ~9 min

Neural vulnerability in Huntington’s disease tied to release of mitochondrial RNA

Unique survey of gene expression by cell type in humans and mice reveals several deficits affecting the most vulnerable neurons.

David Orenstein | Picower Institute for Learning and Memory • mit
July 21, 2020 • ~7 min

Research highlights immune molecule’s complex role in Huntington’s disease

Knocking out the immune cytokine IL-6 exacerbates symptoms in HD model mice, affects neural connection genes.

David Orenstein | Picower Institute for Learning and Memory • mit
June 8, 2020 • ~4 min

Counting your antigens

A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.

Bendta Schroeder | Koch Institute • mit
June 2, 2020 • ~9 min

Older people are at more risk from COVID-19 because of how the immune system ages

Different demographics are more or less vulnerable to serious complications from the coronavirus. A virologist explains the aging-related changes in how immune systems work that are to blame.

Brian Geiss, Associate Professor of Microbiology, Immunology & Pathology, Colorado State University • conversation
March 19, 2020 • ~7 min

Tool to help decision-makers during the coronavirus outbreak

Harvard’s Global Health Institute puts its research expertise into motion, helping hospitals assess capacity and quality of care so they can prepare for COVID-19 patients appropriately.

Mary Todd Bergman • harvard
March 18, 2020 • ~6 min

Technique identifies T cells primed for certain allergies or infections

Researchers develop a method to isolate and sequence the RNA of T cells that react to a specific target.

Anne Trafton | MIT News Office • mit
Nov. 19, 2019 • ~8 min

Ragon Institute receives major gift to expand research into autoimmune diseases

Immunology research at the Ragon Institute of MGH, MIT, and Harvard has advanced an HIV vaccine into the clinic, and will diversify thanks to a major gift from Phillip T. and Susan M. Ragon.

Mary Todd Bergman • harvard
Sept. 19, 2019 • ~9 min

AAAS Golden Goose Awards honor basic research that benefits humankind

Harvard-trained researchers win Golden Goose Awards from the American Association for the Advancement of Science.

Mary Todd Bergman • harvard
Sept. 11, 2019 • ~10 min

/

10